Sprott, H; Glatzel, M; Michel, B A (2004). Treatment of myositis with etanercept (Enbrel®), a recombinant human soluble fusion protein of TNF-α type II receptor and IgG1. Rheumatology, 43(4):524-526.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | National licences > 142-005 |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Rheumatology
Health Sciences > Pharmacology (medical) |
| Language: | English |
| Date: | 1 April 2004 |
| Deposited On: | 19 Oct 2018 07:19 |
| Last Modified: | 26 Jan 2022 18:01 |
| Publisher: | Oxford University Press |
| ISSN: | 1462-0324 |
| OA Status: | Hybrid |
| Free access at: | Publisher DOI. An embargo period may apply. |
| Publisher DOI: | https://doi.org/10.1093/rheumatology/keh062 |
Download
Preview
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 145kB
View at publisher
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 145kB
View at publisher
Sprott, H